Lipid accumulation product: A powerful marker of metabolic syndrome in healthy population

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 559-567

  Taverna, Mariano J ^a   Martínez Larrad, María T ^b   Frechtel, Gustavo D ^a   Serrano Ríos, Manuel ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID ACCUMULATION PRODUCT; LIPID ANALYSIS; MALE; METABOLIC SYNDROME X; PHYSICAL PARAMETERS; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; DIAGNOSTIC TEST ACCURACY STUDY; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; SPAIN; VALIDATION PROCESS;

ADULT; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RADIOIMMUNOASSAY; TRIGLYCERIDES;

EID: 79953184684     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1039     Document Type: Article

References (26)

1. Gallagher EJ, LeRoith D & Karnieli E. The metabolic syndrome - from insulin resistance to obesity and diabetes. Endocrinology and Metabolism Clinics of North America 2008 37 559-579. (doi:10.1016/j.ecl.2008.05.002)
2. Tellechea ML, Aranguren F, Martínez-Larrad MT, Serrano-Ríos M, Taverna MJ & Frechtel GD. Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care 2009 32 e85. (doi:10.2337/dc08-2284)
3. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovascular Disorders 2005 5 26. (doi:10.1186/1471-2261-5-26)
4. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes. Diabetes Care 2006 29 151-153. (doi:10.2337/diacare.29.01. 06.dc05-1805)
5. Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, Lopez A, Fernandez-Alvarez J, Riviriego J, Serrano-Rios M & Grupo de Estudio de Atencion Primaria de Segovia. Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia. Medicina Clinica 2005 125 481-486. (doi:10.1157/13080210)
6. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P & Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 3160-3167. (doi:10.2337/diacare.26.11.3160)
7. Levy JC, Matthews DR & Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192. (doi:10.2337/diacare.21.12.2191)
8. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr & Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 109 433-438. (doi:10.1161/01.CIR.0000111245.75752. C6)
9. Alberti KG, Zimmet P & Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 1059-1062. (doi:10.1016/S0140-6736(05) 67402-8)
10. Sumner AE & Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008 196 696-703. (doi:10.1016/j.atherosclerosis.2006.12.018)
11. Hanley JA & Mcneil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 148 839-843. (Pubitemid 13033817)
12. McKenzie D, Vida S, Mackinnon AJ, Onghena P & Clarke D. Accurate confidence intervals for measures of test performance. Psychiatry Research 2007 69 207-209. (doi:10.1016/S0165-1781(96)02952-6)
13. Mossman D. Resampling techniques in the analysis of nonbinormal ROC data. Medical Decision Making 1995 15 358-366. (doi:10.1177/0272989X9501500406)
14. Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Computers in Biology and Medicine 2000 30 127-134. (doi:10.1016/S0010-4825(00) 00006-8)
15. MacLean DR, Petrasovits A, Connelly PW, Joffres M, O'Connor B & Little JA. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Canadian Journal of Cardiology 1999 15 434-444. (Pubitemid 29224875)
16. Dobbelsteyn CJ, Joffres MR, MacLean DR & Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. International Journal of Obesity and Related Metabolic Disorders 2001 25 652-661. (doi:10.1038/sj.ijo.0801582)
17. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF & Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 1039-1049. (doi:10.1161/ATVBAHA.107.159228)
18. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R & Association for Weight Management and Obesity Prevention; NAASO; Obesity Society; American Society for Nutrition; American Diabetes Association. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 2007 30 1647-1652. (doi:10.2337/dc07-9921)
19. Cordero A, Laclaustra M, León M, Casasnovas JA, Grima A, Luengo E, Ordoñez B, Bergua C, Bes M, Pascual I, Alegría E & MESYAS Registry Investigators. Comparison of serum lipid values in subjects with and without the metabolic syndrome. American Journal of Cardiology 2008 102 424-428. (doi:10.1016/j.amjcard.2008.03.079)
20. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C & Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine 2003 139 802-809.
21. Kannel WB, Vasan RS, Keyes MJ, Sullivan LM & Robins SJ. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). American Journal of Cardiology 2008 101 497-501. (doi:10.1016/j.amjcard.2007.09.109)
22. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT & Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 2009 59 299-304. (doi:10.1016/j.metabol.2009.07.027)
23. Stern MP, Williams K & Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Annals of Internal Medicine 2002 136 575-581.
24. Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, Kuk JL, Seidell JC, Snijder MB, Sørensen TI & Després JP. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obesity Reviews 2008 9 312-315. (doi:10.1111/j.1467-789X.2007.00411.x)
25. Ioachimescu AG, Brennan DM, Hoar BM & Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity 2010 18 1836-1844. (doi:10.1038/oby.2009. 453)
26. Bedogni G, Kahn HS, Bellentani S & Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterology 2010 10 98. (doi:10.1186/1471-230X-10-98)